C2C Advanced (C2C)

FairStock Score: 60/100 — STEADY

Score breakdown: P/E: 2/3 · ROCE: 2/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• ROCE of 26.17% indicates strong capital efficiency
• Sales growth of 52.94% and profit growth of 143.17% show powerful momentum
• P/E of 13.52 with PEG of 0.14 suggests undervaluation relative to earnings growth
• Piotroski F-Score of 7/9 signals solid fundamental health
• Latest quarter net profit of ₹24 Cr on sales of ₹66 Cr implies roughly 36% net margin

Concerns

• Zero dividend yield means no cash return to shareholders
• Book value, P/B, and debt/equity not provided, limiting balance-sheet margin of safety
• Promoter holding of 41.29% is moderate and needs monitoring for alignment or pledge risks
• Price near 52-week high of ₹527.80 leaves little cushion if growth slows

AI Analysis

When I look at C2C Advanced, I see a small aerospace and defense company that is growing at a pace most businesses only dream of. Sales are up nearly 53%, and profits have jumped 143%. That kind of profit growth outpacing sales suggests real operating leverage. The latest quarter shows the point: revenue of ₹66 Cr produced ₹24 Cr in net profit, a margin around 36%. That is impressive for any industry, let one heavily dependent on government and institutional orders. ROCE of 26.17% tells me management is putting capital to work efficiently. The Piotroski F-Score of 7 out of 9 also supports a fundamentally healthy business, not just a story stock. At ₹510.60, the market cap is only ₹578 Cr, with a P/E of 13.52. For a company growing earnings this fast, that is remarkably inexpensive. The PEG ratio of 0.14 is almost too good to be true. Buffett would say: if the growth is durable, the market is not giving C2C credit. But I must pause. Graham always demanded a balance sheet. Here, book value, P/B, and debt-to-equity are not available. That worries me. A zero dividend yield means all returns must come from the business itself. Promoter holding of 41.29% is acceptable, but I would want more alignment in a small-cap defense play. The stock is also near its 52-week high of ₹527.80, so the obvious bargain is gone. This looks like a fast grower, not a Graham-style asset play. I would need to study the order book, debt, and cash flows deeply before committing. The numbers shown are attractive, but a prudent investor must see what is hidden behind them.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer